Your fact-checks will appear here
Family name
Bacopa monnieri has been tested in a modest but consistent body of randomized, placebo‑controlled trials that most systematic reviews and a 2013 meta‑analysis conclude show potential cognitive benefit...
Multiple randomized, double-blind, placebo-controlled trials have tested standardized Bacopa monnieri extracts (typically 300 mg/day or 150–320 mg twice daily) and found mixed cognitive results: sever...
has accrued several randomized, placebo‑controlled trials reporting cognitive benefits—most commonly improvements in memory retention, verbal recall, or speed of attention—with study durations typical...
Randomized, placebo‑controlled clinical trials of Bacopa monnieri in healthy adults span small‑to‑moderate sample sizes and mixed results: several older trials report memory or attention improvements,...
Randomized controlled trials and systematic reviews provide modest, sometimes consistent evidence that Bacopa monnieri can improve certain memory domains after weeks to months of use, while huperzine ...